The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats

Abstract

Sex hormones modulate the action of both cytokines and the renin-angiotensin system. However, the effects of angiotensin I-converting enzyme (ACE) on the proinflammatory and anti-inflammatory cytokine levels in male and female spontaneously hypertensive rats (SHR) are unclear. We determined the relationship between ACE activity, cytokine levels and sex differences in SHR. Female (F) and male (M) SHR were divided into 4 experimental groups each (n = 7): sham + vehicle (SV), sham + enalapril (10 mg/kg body weight by gavage), castrated + vehicle, and castrated + enalapril. Treatment began 21 days after castration and continued for 30 days. Serum cytokine levels (ELISA) and ACE activity (fluorimetry) were measured. Male rats exhibited a higher serum ACE activity than female rats. Castration reduced serum ACE in males but did not affect it in females. Enalapril reduced serum ACE in all groups. IL-10 (FSV = 16.4 ± 1.1 pg/mL; MSV = 12.8 ± 1.2 pg/mL), TNF-α (FSV = 16.6 ± 1.2 pg/mL; MSV = 12.8 ± 1 pg/mL) and IL-6 (FSV = 10.3 ± 0.2 pg/mL; MSV = 7.2 ± 0.2 pg/mL) levels were higher in females than in males. Ovariectomy reduced all cytokine levels and orchiectomy reduced IL-6 but increased IL-10 concentrations in males. Castration eliminated the differences in all inflammatory cytokine levels (IL-6 and TNF-α) between males and females. Enalapril increased IL-10 in all groups and reduced IL-6 in SV rats. In conclusion, serum ACE inhibition by enalapril eliminated the sexual dimorphisms of cytokine levels in SV animals, which suggests that enalapril exerts systemic anti-inflammatory and anti-hypertensive effects.

SHR; Enalapril; Sexual dimorphism; Angiotensin I-converting enzyme; Cytokines IL-10, IL-6 and TNF-α

Introduction

Angiotensin II (Ang II) is directly involved in various biological functions including cell growth and proliferation, mediation of oxidative stress ¹, and key events associated with the inflammatory process ²,³. Ang II increases vascular permeability, recruits inflammatory cells into tissues, and directly activates infiltrating immunocompetent cells ³. Ang II also acts as a potent proinflammatory mediator, promoting the generation of cytokines and free radicals². Furthermore, sex hormones modulate the action of cytokines ⁴ and the renin-angiotensin system (RAS) ⁵.

Previous studies have demonstrated that differences in autoimmune disease susceptibility between sexes may be due to differences in cytokine production after autoantigen-specific stimulation ⁶. Estrogens have been shown to inhibit mRNA expression levels of platelet-derived growth factor-A, IL-1, and IL-6 mRNA in human vascular smooth muscle cells, a finding that suggests the anti-inflammatory effects of estrogens ⁷. Similarly, in vitro evidence has shown that testosterone may influence the expression of proinflammatory and anti-inflammatory cytokines ⁸-¹⁰. Differences between males and females have been found in components of the RAS, such as differences in the concentrations of prorenin, Ang II, and angiotensinogen in humans ¹¹ and animals¹²,¹³. In the hypertensive rat model (mRen(2).Lewis rat), angiotensin I-converting enzyme (ACE) activity was higher in males than in females ¹², and sexual dimorphisms in prorenin levels have been observed in humans (prorenin levels in men were significantly higher than in women) ¹¹.

The pleiotropic anti-inflammatory effects of the ACE inhibitors have been well established ¹³,¹⁴. However, the effects of ACE on proinflammatory and anti-inflammatory cytokine levels in male and female SHR are not clear. Therefore, the present study was designed to investigate: 1) if there are sex differences in inflammatory biomarkers (IL-10, IL-6, TNF-α) in spontaneous hypertension, 2) if sex hormones play a role in these sex differences, and 3) if an ACE inhibitor enalapril interferes with inflammatory biomarkers in male and female SHR.

Material and Methods

Animals

The study was conducted on 12-week-old male and female SHR that initially weighed 150 ± 5 g (females) and 230 ± 5 g (males) and that had free access to food and water. The rats' body weight was monitored during the experiments. The animals were housed in standard plastic cages at a constant temperature of 22°C and on a 12-h light-dark cycle.

The procedures were carried out in compliance with the guidelines for the ethical use of animals in scientific research and were approved by the Ethics Committee of Universidade Federal do Espírito Santo (#023/2009). All surgical procedures were carried out under ketamine (70 mg/kg, ip) and xylazine (10 mg/kg, ip) anesthesia.

Experimental design

Castration. Female rats were subjected to a skin incision of 1 to 1.5 cm and a muscular incision to open the peritoneal cavity for the connection of the uterine tubules and ovary removal. The peritoneal cavity was then cleaned and sutured. The estrous cycle of the sham rats was monitored continuously with vaginal smears. This group was subjected to the experimental protocol on the day of proestrus. Orchiectomy was performed through an anterior median incision in the scrotum and each testicle was exposed through the surgical incision. The ductus deferens was isolated, ligated, and severed, allowing the testicle to be removed. The incision was then closed and sutured with 3-0 chromic catgut.

The rats were divided into 4 experimental groups (n = 7) of female and male rats as follows: sham-operated vehicle (SV), sham-operated treated with enalapril (SE), castrated + vehicle (CV), and castrated and treated with enalapril (CE). The treatments were started 21 days after castration and continued for 30 days. Enalapril maleate (Sigma, USA) was dissolved in water, and 10 mg enalapril/kg body weight was administered daily by gavage. A dose of 10 mg·kg^-1·day^-1 has been shown to reduce blood pressure in male SHR of this age ¹⁵. The rats' systolic blood pressure (SBP) was measured at the onset of the experiment and after 7 weeks of the experimental period (21 days after castration and after 28 days of treatment).

Blood pressure determination

The SBP of conscious rats was measured using a tail-cuff manometer manufactured by IITC Life Science Inc. (USA). The animals were placed inside a warming chamber (about 34°C) for 30 min before the measurements. The aim of the procedure was to calm the animals and dilate the blood vessels in the tail. The arterial blood pressure of each animal was measured at least three times. Any changes in pressure were reported as baseline value variation.

Determining estrous cycle phase

Daily vaginal smears were taken from each female rat as previously described ¹⁶ to confirm that their estrous cycles were proceeding normally. The vaginal epithelial cells were examined by microscopy for at least 7 consecutive days before the experiment. The swabs were performed between 8:00 and 10:00 am to maintain consistency. The females exhibiting normal estrous cycles were killed at proestrus between 9:00 am and 1:00 pm.

Measurement of cytokine levels, ACE activity and hormone levels

After measuring the SBP, the rats were decapitated without anesthesia, and 8 mL blood was collected into empty tubes to obtain serum (4 mL) for the determination of cytokines and plasma (4 mL) for the determination of ACE activity. The blood samples were centrifuged at 4°C and 1000 g(Eppendorf, Germany) for 15 min. Serum and plasma were stored at -80°C. IL-6, IL-10, and TNF-α levels were measured by ELISA according to manufacturer specifications (Biosource International, USA). The experiments were performed in duplicate.

The proteolytic activity assay that was used to determine ACE activity in plasma utilized Abz-FRK(Dnp)P-OH (Aminotech Pesquisa e Desenvolvimento, Brazil) as a substrate, which is ideal for studies of enzyme kinetics and the analysis of the somatic activity of the C- and N-terminal domains of ACE. The assay methodology was adapted to a fluorescence plate reader with a 96-well format and utilized excitation at 320 nm and emission at 420 nm. ACE activity is reported in arbitrary fluorescence units (AFU) ¹⁷.

Testosterone and estradiol concentrations were determined by ELISA. Testosterone (10 µL serum sample; AccuBind™, Monobind Inc., USA; sensitivity of 0.038 ng/mL) and estradiol (25 µL serum sample; AccuBind™, Monobind Inc.; sensitivity of 0.0065 ng/mL) were measured in duplicate. The uterus was removed and weighed.

Statistical analysis

Data are reported as means ± SE. Statistical analysis was performed by repeated measures two-way ANOVA followed by the Fisher least significant differencespost hoc comparison for all statistical analyses. A P value <0.05 was considered to be statistically significant. The statistical analyses were performed with the GB Stat software (USA).

Results

Blood pressure and body weight

Table 1 shows the SBP of all of the groups studied. The initial SBP of the male (M) groups (MSV, MCV, MSE, and MCE) was higher than that of the female (F) groups (FSV, FCV, FSE, and FCE). After the experimental period, the SBP of male rats (MSV and MCV) continued to be higher than the SBP of female rats (FSV, FCV). Castration did not alter the blood pressure of either sex. As expected, treatment with enalapril reduced the SBP in both the non-castrated (MSE and FSE) and the castrated (MCE and FCE) groups, resulting in similar blood pressure levels in all of these groups. However, the observed percent decline was greater in males (SE = -30%, CE = -33%, P < 0.05) than in females (SE = -19%, CE = -25%).

The initial and final body weights (BW) of the male groups (MSV, MCV, MSE, MCE) were different from those of the respective female groups (FSV, FCV, FSE, FCE). All groups had an increase in their final BW after the experimental period. No differences were detected in the initial weight of the female groups; however, after the experimental period, the ovariectomized females (FCV and FCE) exhibited an increase in final BW compared to the sham females (FSV and FSE;Table 1).

ACE activity

Male rats exhibited higher ACE activity than female rats (MSV = 1500 ± 131 AFU; FSV = 1234 ± 80 AFU). In comparison with the sham groups (MSV and FSV), castration greatly reduced the ACE activity of male rats (MCV = 790 ± 58 AFU) but did not affect the ACE activity of female rats (FCV = 1161 ± 39 AFU). When compared to vehicle treatment, enalapril treatment reduced the ACE activity in the non-castrated (MSE = 59 ± 20 AFU, FSE = 21 ± 4 AFU vs MSV and FSV, respectively) and castrated (MCE = 8 ± 5 AFU, FCE = 32 ± 3 AFUvs MCV and FCV, respectively) rats of both sexes (Figure 1).

Figure 1
Plasma levels of angiotensin-converting exzyme (ACE) activity (arbitrary fluorescence units, AFU) in SV (sham + vehicle), SE (sham + enalapril), CV (castrated + vehicle), and CE (castrated + enalapril) groups. Data are reported as means ± SE. *P < 0.05vs females of the same group; ⁺P < 0.05 vs sham vehicle animals of the same sex;^#P < 0.05 vs castrated animals of the same sex (two-way ANOVA and Fisher test).

Cytokines

IL-10. Figure 2A shows the sex differences in serum IL-10 levels. The male sham vehicle group had a lower IL-10 level than the female sham vehicle group (MSV = 12.8 ± 1.2 pg/mL vs FSV = 16.4 ± 1.1 pg/mL). In comparison with the sham groups, orchiectomy increased (MCV = 15.9 ± 2 pg/mL) and ovariectomy reduced (FCV = 8.9 ± 0.9 pg/mL) IL-10 levels. When compared to the vehicle treatment, enalapril treatment increased the serum IL-10 concentrations in the male (MSE = 19.2 ± 3.1 pg/mL) and female (FSE = 23.5 ± 1.8 pg/mL) sham groups. Enalapril treatment also increased the IL-10 levels of the castrated groups of male (MCE = 19.8 ± 0.7 pg/mL) and female (FCE = 20.1 ± 1.8 pg/mL) rats.

Figure 2
Cytokine levels. A, IL-10, B, TNF-α, and C, IL-6 levels of SV (sham + vehicle), SE (sham + enalapril), CV (castrated + vehicle), and CE (castrated + enalapril) groups, as measured by ELISA. Data are reported as means ± SE. *P < 0.05 vs females of the same group;⁺P < 0.05 vs sham vehicle animals of the same sex; ^#P< 0.05 vs castrated animals of the same sex (two-way ANOVA and Fisher test).

TNF-α. We observed different TNF-α concentrations (Figure 2B) between the male (MSV = 12.8 ± 1 pg/mL) and female sham vehicle groups (FSV = 16.6 ± 1.2 pg/mL). Castration did not alter the TNF-α concentration in males (MCV = 12.7 ± 1 pg/mL), but decreased it in female rats (FCV = 10.9 ± 0.8 pg/mL) relative to the sham vehicle group. Enalapril treatment did not change the TNF-α concentration in males (MSE = 14.1 ± 0.5 pg/mL), but it decreased the TNF-α concentration in the female rats (FSE = 13 ± 1 pg/mL) relative to the sham vehicle group. Treating castrated animals with enalapril did not alter the concentration of TNF-α in males (MCE = 14.2 ± 1.2 pg/mL) or females (FCE = 12.7 ± 1.6 pg/mL) relative to the CV groups, but it eliminated the sexual dimorphism.

IL-6. The serum concentrations of IL-6 are shown in Figure 2C. We observed sexual dimorphism in the IL-6 concentrations of the sham vehicle groups (MSV = 7.2 ± 0.2 pg/mLvs FSV = 10.3 ± 0.2 pg/mL). Castration decreased the IL-6 concentrations in male (MCV = 4.2 ± 0.2 pg/mL) and female (FCV = 4.0 ± 0.6 pg/mL) rats relative to the sham vehicle groups. Enalapril treatment reduced IL-6 concentrations in the male (MSE = 3.2 ± 0.9 pg/mL) and female (FSE = 3.5 ± 0.2 pg/mL) sham groups and eliminated the difference between sexes. However, the association of enalapril treatment with castration failed to change the IL-6 concentrations in either the male (MCE = 5.9 ± 0.4 pg/mL) or female (FCE = 5.5 ± 0.6 pg/mL) rats relative to the values obtained for the respective CV groups.

Hormone levels and uterine weight

Castration resulted in significant reductions in the levels of estradiol in female rats and in the levels of testosterone in male rats. Enalapril treatment did not alter the serum levels of estradiol or testosterone. As expected, ovariectomy reduced the uterine weight/body weight ratio (Table 1).

Discussion

It has been demonstrated that sex hormones and the immune system are connected ⁴,⁸-¹⁰ and that differences in hormone levels between sexes can alter cytokine production profiles ¹⁸. One of the main findings of the present study was the observation of sex dimorphisms in serum IL-10, TNF-α, and IL-6 levels in SHR. Furthermore, data from clinical and experimental studies have emphasized the important roles of ACE inhibitors in affecting non-hemodynamic, immune-mediated functions such as cytokine production ¹⁹,²⁰. In the present study, we investigated the effect of the ACE inhibitor enalapril on systemic cytokine production in SHR and showed that enalapril increased the IL-10 levels and decreased the IL-6 levels of both male and female hypertensive animals.

The data presented in this study demonstrated that male SHR had a higher SBP than female SHR. Castration did not alter this parameter and the differences in SBP levels were maintained across the sexes. Female SHR that were subjected to ovariectomy did not show changes in their blood pressure ²¹,²². Previous studies have shown that castration lowered the blood pressure of male SHR rats ²³-²⁵; however, the initial blood pressure detected in our animals was higher than in previous studies, and the rats were castrated at a younger age (4 or 5 weeks) and observed for a longer period of time in our study ²³,²⁵. However, it has not been clearly established that the removal of sex hormones influences the development of hypertension. Furthermore, SBP was evaluated by direct measurements in anesthetized animals ²³-²⁵.

Our results identified sexual dimorphisms in the levels of the cytokines studied. Female SHR had higher levels of both the pro- and anti-inflammatory cytokines than male SHR. Establishing an estrogen-deficient state in female rats by ovariectomy reduced the levels of all the cytokines studied, whereas reducing the testosterone level in male rats by orchiectomy resulted in a different cytokine profile. Indeed, the effect of the female sex hormones appears to be evident regarding cytokine levels; ovariectomy did not change the ACE activity or the SBP but reduced all the cytokines studied when compared to the sham vehicle group. Orchiectomy decreased the ACE activity without changing the SBP in male rats. On the other hand, orchiectomy enhanced IL-10 and reduced IL-6 levels, indicating a relationship between ACE activity and the levels of these cytokines that was independent of the SBP. Thus, in female rats the differences in the cytokine levels between the sham and castrated animals are influenced by the sex hormones independent of ACE activity and SBP. However, in male rats the differences in cytokine levels are influenced by ACE activity, which was reduced after castration. These data suggest that sex hormones influence the serum cytokine levels in SHR, but generalizations cannot be made.

Estrogen appears to have a concentration-dependent effect on immune response polarization as low levels of exogenous estrogen were shown to support a proinflammatory Th1 (IL-1, IFN) response, while high doses of estrogen support a Th2 response by upregulating the production of IL-4, IL-10, and IL-6 ²⁶,²⁷. One of the strengths of the present study was that the cytokine measurements were carried out in sham females during proestrus, the stage with the highest endogenous estrogen concentrations ²⁷. This might be responsible for the higher IL-10, IL-6, and TNF-α concentrations observed in the female sham vehicle group because ovariectomy decreased the cytokine concentrations.

Among the sham groups, male rats displayed lower IL-10, IL-6, and TNF-α concentrations than female rats. A direct relationship between testosterone and ACE activity has been identified ²⁸, and we demonstrated that castration of male SHR reduced ACE activity. Therefore, the increase in IL-10 levels and the decrease in IL-6 levels observed after castration could have been due to ACE inhibition. Castration or blockade of the testosterone receptor with flutamide improved myocardial function after acute ischemia-reperfusion by decreasing the levels of proinflammatory cytokines ²⁹. There are conflicting reports in the literature regarding the relationship between TNF-α and testosterone, with results showing both increases ³⁰ and decreases ⁸,²⁹,³⁰ in TNF-α levels in the presence of testosterone.

We showed that male SHR had a higher serum ACE activity than female SHR and that castration only affected the ACE activity of male rats. Similarly, Pendergrass et al. ¹² showed that male hypertensive mRen(2).Lewis male rats had a higher plasma ACE activity than females, and Lim et al. ²⁸ reported similar findings in mice. Another study consistent with our results demonstrated that normotensive female rats subjected to ovariectomy did not show altered ACE activity ³¹. Other studies showed that there were no changes in the pituitary ³² or circulating ³³ ACE activity levels during the normal estrous cycle and that ACE activity was only reduced after exogenous estrogen administration ³²,³³. This suggested that ACE activity in plasma was only affected by the administration of exogenous estrogen ³¹,³³.

A sex difference in the bradykinin (BK) system has been reported ³⁴, and the level of BK may have contributed to our results. Although the inhibition of ACE determines the increase in BK levels³⁵, we cannot assume an important role for the bradykinin system in our results. Consistent with Reckelhoff et al. ²¹, we demonstrated that there were no differences in blood pressure levels between intact and ovariectomized females. Therefore, because the decrease in blood pressure after enalapril treatment was the same in the ovariectomized and sham rats, despite the reduction in the BK system in ovariectomized rats ³⁶, it is debatable whether the BK system played an important role in the hypotensive effect of enalapril. Additionally, a study by Majima et al. ³⁷ found that the levels of BK needed to reduce the blood pressure of SHR males were 20 to 100 times higher than the level produced by the ACE inhibitor captopril. In another study, inhibition of BK with the BK antagonist was shown to have no effect on the basal blood pressure of SHR or WKY ³⁸.

It is well established that Ang II may contribute significantly to the development of diverse forms of vascular disease by activating the components of the inflammatory response ³⁹ and that ACE inhibitors have pleiotropic anti-inflammatory effects ¹³, most likely by reducing activation of the nuclear factor-kappaB system and reversing the elevated expression of proinflammatory cytokines ⁵. We therefore used enalapril to assess the influence of ACE on cytokine levels in both male and female rats. First, we demonstrated that enalapril treatment decreased both the blood pressure and ACE activity of intact and castrated animals. Second, the pharmacological blockade of ACE led to changes in the cytokine levels of the sham animals. The inhibition of ACE decreased IL-6 and TNF-α levels and increased IL-10 levels in female rats and enhanced IL-10 levels, reduced IL-6 levels, and did not change TNF-α levels in male rats. However, castration increased IL-10 levels without affecting the proinflammatory cytokine levels, despite reductions in the ACE activity and blood pressure compared to the vehicle controls. Enalapril treatment markedly affected the serum IL-10 levels in both castrated and non-castrated hypertensive rats. It is known that endogenous IL-10 limits Ang II-mediated increases in IL-6, oxidative stress, and vascular dysfunction ¹³. Therefore, enalapril-mediated increases in IL-10 and reductions in IL-6 may protect against Ang II-induced vascular dysfunction and mediate vascular protection during hypertension and other vascular diseases where Ang II plays a major role ³⁹.

The results presented in this report are consistent with studies that demonstrated similar cytokine-modulating effects of ACE inhibitors in various experimental models¹³,⁴⁰. One could argue, however, that the effects of enalapril treatment on the cytokine expression profiles observed were due to a direct effect of blocking Ang II activity or as a consequence of reduced hypertension. Treatment with enalapril exerted important anti-inflammatory activity in normotensive patients¹³ and animals ¹⁴. Based on our findings, the reduction in ACE activity appears to influence the cytokine levels independently of the reduction in blood pressure. For example, in the castrated male rats, ACE activity is reduced without a reduction in SBP, yet we observed an increase in IL-10 levels and a decrease in IL-6 levels, which shows that testosterone influences the activity of ACE ²⁷. Enalapril treatment did not alter the proinflammatory cytokines in either male or female castrated rats despite a decrease in blood pressure. Therefore, enalapril treatment only changes the proinflammatory cytokine profile in the presence of the sex hormones, regardless of the reduction in SBP.

This study identified sexual dimorphisms in serum cytokine levels in SHR; sex hormones differentially modulate levels of specific cytokines; male, but not female, sex hormones modulate ACE activity; ACE inhibition produces systemic anti-inflammatory and anti-hypertensive effects in SHR regardless of sex. These data support the evidence that both sex hormones and the RAS affect cytokine expression profiles.

References

• ¹ Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121-128, doi: 10.1016/j.amjcard.2006.01.059.
• ² Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001; 10: 321-329, doi: 10.1097/00041552-200105000-00005.
• ³ Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900, doi: 10.1016/S1357-2725(02)00271-6.
• ⁴ Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005; 11: 411-423, doi: 10.1093/humupd/dmi008.
• ⁵ Miguel-Carrasco JL, Zambrano S, Blanca AJ, Mate A, Vazquez CM. Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm 2010; 7: 21, doi: 10.1186/1476-9255-7-21.
• ⁶ Cutolo M, Accardo S, Villaggio B, Barone A, Sulli A, Coviello DA, et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996; 81: 820-827, doi: 10.1210/jc.81.2.820.
• ⁷ Kikuchi N, Urabe M, Iwasa K, Okubo T, Tsuchiya H, Hosoda T, et al. Atheroprotective effect of estriol and estrone sulfate on human vascular smooth muscle cells. J Steroid Biochem Mol Biol 2000; 72: 71-78, doi: 10.1016/S0960-0760(99)00149-1.
• ⁸ D'Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, Ferlazzo V, et al. Sex hormones modulate inflammatory mediators produced by macrophages. Ann N Y Acad Sci 1999; 876: 426-429, doi: 10.1111/j.1749-6632.1999.tb07667.x.
• ⁹ Bebo BF Jr, Schuster JC, Vandenbark AA, Offner H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999; 162: 35-40.
• ¹⁰ Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 2001; 167: 2060-2067.
• ¹¹ Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998; 16: 853-862, doi: 10.1097/00004872-199816060-00017.
• ¹² Pendergrass KD, Pirro NT, Westwood BM, Ferrario CM, Brosnihan KB, Chappell MC. Sex differences in circulating and renal angiotensins of hypertensive mRen(2).Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol 2008; 295: H10-H20, doi: 10.1152/ajpheart.01277.2007.
• ¹³ Krysiak R, Okopien B. Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease. Pharmacol Rep 2008; 60: 514-523.
• ¹⁴ Albuquerque D, Nihei J, Cardillo F, Singh R. The ACE inhibitors enalapril and captopril modulate cytokine responses in Balb/c and C57Bl/6 normal mice and increase CD4(+)CD103(+)CD25(negative) splenic T cell numbers. Cell Immunol 2010; 260: 92-97, doi: 10.1016/j.cellimm.2009.09.006.
• ¹⁵ Uggere TA, Abreu GR, Sampaio KN, Cabral AM, Bissoli NS. The cardiopulmonary reflexes of spontaneously hypertensive rats are normalized after regression of left ventricular hypertrophy and hypertension. Braz J Med Biol Res 2000; 33: 589-594, doi: 10.1590/S0100-879X2000000500014.
• ¹⁶ Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, et al. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005; 146: 1650-1673, doi: 10.1210/en.2004-1142.
• ¹⁷ Carmona AK, Schwager SL, Juliano MA, Juliano L, Sturrock ED. A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay. Nat Protoc 2006; 1: 1971-1976, doi: 10.1038/nprot.2006.306.
• ¹⁸ Grossman CJ. Interactions between the gonadal steroids and the immune system. Science 1985; 227: 257-261, doi: 10.1126/science.3871252.
• ¹⁹ Gullestad L, Aukrust P, Ueland T, Espevik T, Yee G, Vagelos R, et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol 1999; 34: 2061-2067, doi: 10.1016/S0735-1097(99)00495-7.
• ²⁰ Schieffer B, Bunte C, Witte J, Hoeper K, Boger RH, Schwedhelm E, et al. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol 2004; 44: 362-368, doi: 10.1016/j.jacc.2004.03.065.
• ²¹ Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 2000; 35: 480-483, doi: 10.1161/01.HYP.35.1.480.
• ²² Jazbutyte V, Hu K, Kruchten P, Bey E, Maier SK, Fritzemeier KH, et al. Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension 2006; 48: 579-586, doi: 10.1161/01.HYP.0000240053.48517.c7.
• ²³ Tatchum-Talom R, Eyster KM, Kost CK Jr, Martin DS. Blood pressure and mesenteric vascular reactivity in spontaneously hypertensive rats 7 months after gonadectomy. J Cardiovasc Pharmacol 2011; 57: 357-364, doi: 10.1097/FJC.0b013e31820b7dc9.
• ²⁴ Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 1998; 31: 435-439, doi: 10.1161/01.HYP.31.1.435.
• ²⁵ Song J, Martin DS. Rho kinase contributes to androgen amplification of renal vasoconstrictor responses in the spontaneously hypertensive rat. J Cardiovasc Pharmacol 2006; 48: 103-109, doi: 10.1097/01.fjc.0000245403.45406.d8.
• ²⁶ Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158: 446-451.
• ²⁷ Nicot A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 2009; 14: 4477-4515, doi: 10.2741/3543.
• ²⁸ Lim YK, Retnam L, Bhagavath B, Sethi SK, Bin Ali A, Lim SK. Gonadal effects on plasma ACE activity in mice. Atherosclerosis 2002; 160: 311-316, doi: 10.1016/S0021-9150(01)00576-7.
• ²⁹ Wang M, Tsai BM, Kher A, Baker LB, Wairiuko GM, Meldrum DR. Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2005; 288: H221-H226, doi: 10.1152/ajpheart.00784.2004.
• ³⁰ Ganesan K, Balachandran C, Manohar BM, Puvanakrishnan R. Effects of testosterone, estrogen and progesterone on TNF-alpha mediated cellular damage in rat arthritic synovial fibroblasts. Rheumatol Int 2012; 32: 3181-3188, doi: 10.1007/s00296-011-2146-x.
• ³¹ Dean SA, Tan J, O'Brien ER, Leenen FH. 17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 2005; 288: R759-R766, doi: 10.1152/ajpregu.00595.2004.
• ³² Seltzer A, Pinto JE, Viglione PN, Correa FM, Libertun C, Tsutsumi K, et al. Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 1992; 55: 460-467, doi: 10.1159/000126157.
• ³³ Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 1999; 33: 323-328, doi: 10.1161/01.HYP.33.1.323.
• ³⁴ Bechtloff R, Goette A, Bukowska A, Kahne T, Peters B, Huth C, et al. Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease. Int J Cardiol 2011; 146: 164-170, doi: 10.1016/j.ijcard.2009.06.028.
• ³⁵ Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 1994; 23: 439-449, doi: 10.1161/01.HYP.23.4.439.
• ³⁶ Madeddu P, Emanueli C, Song Q, Varoni MV, Demontis MP, Anania V, et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br J Pharmacol 1997; 121: 1763-1769, doi: 10.1038/sj.bjp.0701255.
• ³⁷ Majima M, Katori M, Ogino M, Saito M, Sugimoto K, Adachi K, et al. Lack of contribution of circulatory kinin elevated by captopril to induce hypotension in normotensive and hypertensive rats. Immunopharmacology 1996; 33: 291-293, doi: 10.1016/0162-3109(96)00044-6.
• ³⁸ Holte HR, Bjornstad-Ostensen A, Berg T. The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats. Br J Pharmacol 1996; 118: 1925-1930, doi: 10.1111/j.1476-5381.1996.tb15626.x.
• ³⁹ Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-2460, doi: 10.1084/jem.20070657.
• ⁴⁰ Niimi R, Nakamura A, Yanagawa Y. Suppression of endotoxin-induced renal tumor necrosis factor-alpha and interleukin-6 mRNA by renin-angiotensin system inhibitors. Jpn J Pharmacol 2002; 88: 139-145, doi: 10.1254/jjp.88.139.

• First published online February 1, 2013.

Publication Dates

• Publication in this collection
  01 Feb 2013
• Date of issue
  Feb 2013

History

• Received
  7 July 2012
• Accepted
  18 Oct 2012